Kentucky Pediatric and Adult Research

Kentucky Pediatric and Adult Research (KPAR) is a premier independent clinical research site located in Bardstown, Kentucky, specializing in Phase I through IV clinical trials. Founded in 1990 by Dr. Stan L. Block, the center has established a global reputation for its contributions to the development of numerous vaccines and antibiotics, including those for HPV, meningococcal disease, and COVID-19. KPAR operates as a high-volume outpatient research group, collaborating with major pharmaceutical companies, the National Institutes of Health (NIH), and leading academic medical centers. The facility is particularly recognized for its expertise in pediatric infectious diseases, respiratory conditions, and vaccine immunogenicity studies. With a legacy of extensive publication in top-tier medical journals, KPAR remains a critical partner in advancing evidence-based treatments for both children and adults.